Physician profile
Sunmin Park
NPI 1871520601
$4,940.89
in general payments reported to CMS, 2019-2025
19 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $491 · 2021: $596 · 2022: $770 · 2023: $1,001 · 2024: $403 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $1,004.31 | 2019-2025 | Cequa |
| Abbvie INC. | $739.73 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $697.22 | 2019-2021 | |
| Allergan, INC. | $603.79 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $397.79 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $359.21 | 2019-2021 | |
| Oyster Point Pharma, INC. | $226.04 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $137.57 | 2022-2025 | Rocklatan, Tryptyr |
| Horizon Therapeutics Plc | $119.33 | 2022-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $102.61 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $102.15 | 2019-2023 | |
| Akorn, INC. | $94.60 | 2019-2020 | |
| Shire North American Group INC | $88.04 | 2019 | |
| Akorn Operating Company LLC | $82.65 | 2021 | |
| Eyevance Pharmaceuticals LLC | $56.05 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $54.01 | 2021 | |
| Biotissue Holdings INC. | $28.89 | 2023 | |
| Rxsight INC | $27.04 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Thea Pharma INC. | $19.86 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunmin Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.